LAURIE CASIANO: Open Payments
NPI 1851368534 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 20 payments from 6 companies in 2025. Trend: 2023 $641 · 2024 $739 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $259 |
| Gilead Sciences, Inc. | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 2 | $141 |
| Ipsen Biopharmaceuticals, Inc | 2 | $137 |
| Madrigal Pharmaceuticals | 1 | $131 |
| ABBVIE INC. | 2 | $123 |
Products named: TREMFYA, DUPIXENT, IQIRVO, REZDIFFRA, RINVOQ, Livdelzi.
Industry payments across WI — which companies pay providers there.
